Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction

References

• Watson JD, Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature. 1953;171:737–738.
   PubMed Web of Science ®Google Scholar
• Nirenberg M, Leder P, Bernfield M, et al. RNA codewords and protein synthesis, VII. On the general nature of the RNA code. Proc Natl Acad Sci USA. 1965;53:1161–1168.
   PubMed Web of Science ®Google Scholar
• Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975;98:503–517.
   PubMed Web of Science ®Google Scholar
• Alwine JC, Kemp DJ, Stark GR. Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci USA. 1977;74:5350–5354.
   PubMed Web of Science ®Google Scholar
• Renart J, Reiser J, Stark GR. Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera: a method for studying antibody specificity and antigen structure. Proc Natl Acad Sci USA. 1979;76:3116–3120.
   PubMed Web of Science ®Google Scholar
• Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 1977;74:5463–5467.
   PubMed Web of Science ®Google Scholar
• Vockley JG, Niederhuber JE. Diagnosis and treatment of cancer using genomics. BMJ. 2015;350:h1832.
   PubMed Web of Science ®Google Scholar
• Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portal – a one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Papadopoulos N, Velculescu VE, et al. Cancer genome landscapes. Science. 2013;339:1546–1558.
   PubMed Web of Science ®Google Scholar
• McFarland CD, Korolev KS, Kryukov GV, et al. Impact of deleterious passenger mutations on cancer progression. Proc Natl Acad Sci USA. 2013;110:2910–2915.
   PubMed Web of Science ®Google Scholar
• Ellis MJ, Gillette M, Carr SA, et al. Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium. Cancer Discov. 2013;3:1108–1112.
   PubMed Web of Science ®Google Scholar
• Schwanhausser B, Busse D, Li N, et al. Global quantification of mammalian gene expression control. Nature. 2011;473:337–342.
   PubMed Web of Science ®Google Scholar
• Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012;13:227–232.
   PubMed Web of Science ®Google Scholar
• Chen G, Gharib TG, Huang CC, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics. 2002;1:304–313.
   PubMed Web of Science ®Google Scholar
• Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature. 2005;437:376–380.
   PubMed Web of Science ®Google Scholar
• Schuster SC. Next-generation sequencing transforms today’s biology. Nat Methods. 2008;5:16–18.
   PubMed Web of Science ®Google Scholar
• Shen T, Pajaro-Van de Stadt SH, Yeat NC, et al. Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes. Front Genet. 2015;6:215.
   PubMed Web of Science ®Google Scholar
• Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007;318:1108–1113.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061–1068.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61–70.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–337.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499:43–49.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507:315–322.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511:543–550.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–209.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576–582.
   PubMed Web of Science ®Google Scholar
• Nik-Zainal S, Davies H, Staaf J, et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016;534:47–54.
   PubMed Web of Science ®Google Scholar
• Nik-Zainal S, Alexandrov LB, Wedge DC, et al. Mutational processes molding the genomes of 21 breast cancers. Cell. 2012;149:979–993.
   PubMed Web of Science ®Google Scholar
• Jones DT, Jager N, Kool M, et al. Dissecting the genomic complexity underlying medulloblastoma. Nature. 2012;488:100–105.
   PubMed Web of Science ®Google Scholar
• Ramsay AJ, Martinez-Trillos A, Jares P, et al. Next-generation sequencing reveals the secrets of the chronic lymphocytic leukemia genome. Clin Transl Oncol. 2013;15:3–8.
   PubMed Web of Science ®Google Scholar
• Northcott PA, Shih DJ, Peacock J, et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature. 2012;488:49–56.
   PubMed Web of Science ®Google Scholar
• Garraway LA, Lander ES. Lessons from the cancer genome. Cell. 2013;153:17–37.
   PubMed Web of Science ®Google Scholar
• Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007;110:1092–1097.
   PubMed Web of Science ®Google Scholar
• Cazier JB, Rao SR, McLean CM, et al. Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden. Nat Commun. 2014;5:3756.
   PubMed Web of Science ®Google Scholar
• Kiel MJ, Velusamy T, Betz BL, et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med. 2012;209:1553–1565.
   PubMed Web of Science ®Google Scholar
• Kamalakaran S, Varadan V, Janevski A, et al. Translating next generation sequencing to practice: opportunities and necessary steps. Mol Oncol. 2013;7:743–755.
   PubMed Web of Science ®Google Scholar
• Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004;304:1497–1500.
   PubMed Web of Science ®Google Scholar
• Hammerman PS, Sos ML, Ramos AH, et al. Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discov. 2011;1:78–89.
   PubMed Web of Science ®Google Scholar
• Kan Z, Zheng H, Liu X, et al. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res. 2013;23:1422–1433.
   PubMed Web of Science ®Google Scholar
• Narayanan R. Phenome-genome association studies of pancreatic cancer: new targets for therapy and diagnosis. Cancer Genomics Proteomics. 2015;12:9–19.
   PubMed Web of Science ®Google Scholar
• Ramus SJ, Antoniou AC, Kuchenbaecker KB, et al. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Hum Mutat. 2012;33:690–702.
   PubMed Web of Science ®Google Scholar
• Patel JN, McLeod HL, Innocenti F. Implications of genome-wide association studies in cancer therapeutics. Br J Clin Pharmacol. 2013;76:370–380.
   PubMed Web of Science ®Google Scholar
• Thompson ER, Doyle MA, Ryland GL, et al. Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS Genet. 2012;8:e1002894.
   PubMed Web of Science ®Google Scholar
• Barbieri CE, Baca SC, Lawrence MS, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet. 2012;44:685–689.
   PubMed Web of Science ®Google Scholar
• Colombo PE, Milanezi F, Weigelt B, et al. Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction. Breast Cancer Res. 2011;13:212.
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Daigo Y, Katagiri T, et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene. 2003;22:2192–2205.
   PubMed Web of Science ®Google Scholar
• Dyrskjot L. Classification of bladder cancer by microarray expression profiling: towards a general clinical use of microarrays in cancer diagnostics. Expert Rev Mol Diagn. 2003;3:635–647.
   PubMed Web of Science ®Google Scholar
• Cardoso F, van’t Veer LJ, Bogaerts J, et al. 70-Gene signature as an aid to treatment decisions in early-stage breast cancer. N Engl J Med. 2016;375:717–729.
   PubMed Web of Science ®Google Scholar
• Xiao WH, Qu XL, Li XM, et al. Identification of commonly dysregulated genes in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation. Cancer Gene Ther. 2015;22:278–284.
   PubMed Web of Science ®Google Scholar
• Huber-Keener KJ, Liu X, Wang Z, et al. Differential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq data. PLoS One. 2012;7:e41333.
   PubMed Web of Science ®Google Scholar
• Li XX, Zheng HT, Peng JJ, et al. RNA-seq reveals determinants for irinotecan sensitivity/resistance in colorectal cancer cell lines. Int J Clin Exp Pathol. 2014;7:2729–2736.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhu K, Liu F, et al. Identification of somatic mutations in human prostate cancer by RNA-Seq. Gene. 2013;519:343–347.
   PubMed Web of Science ®Google Scholar
• Rezaeian I, Tavakoli A, Cavallo-Medved D, et al. A novel model used to detect differential splice junctions as biomarkers in prostate cancer from RNA-Seq data. J Biomed Inform. 2016;60:422–430.
   PubMed Web of Science ®Google Scholar
• Cui W, Qian Y, Zhou X, et al. Discovery and characterization of long intergenic non-coding RNAs (lincRNA) module biomarkers in prostate cancer: an integrative analysis of RNA-Seq data. BMC Genomics. 2015;16 Suppl 7:S3.
   PubMed Web of Science ®Google Scholar
• Madhamshettiwar PB, Maetschke SR, Davis MJ, et al. INsPeCT: INtegrative Platform for Cancer Transcriptomics. Cancer Inform. 2014;13:59–66.
   PubMedGoogle Scholar
• Wilhelm M, Schlegl J, Hahne H, et al. Mass-spectrometry-based draft of the human proteome. Nature. 2014;509:582–587.
   PubMed Web of Science ®Google Scholar
• Kim MS, Pinto SM, Getnet D, et al. A draft map of the human proteome. Nature. 2014;509:575–581.
   PubMed Web of Science ®Google Scholar
• Surinova S, Schiess R, Huttenhain R, et al. On the development of plasma protein biomarkers. J Proteome Res. 2011;10:5–16.
   PubMed Web of Science ®Google Scholar
• Percy AJ, Chambers AG, Yang J, et al. Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma. Proteomics. 2013;13:2202–2215.
   PubMed Web of Science ®Google Scholar
• Sethi MK, Thaysen-Andersen M, Kim H, et al. Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis. J Proteomics. 2015;126:54–67.
   PubMed Web of Science ®Google Scholar
• Cha S, Imielinski MB, Rejtar T, et al. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology. Mol Cell Proteomics. 2010;9:2529–2544.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Fonslow BR, Shan B, et al. Protein analysis by shotgun/bottom-up proteomics. Chem Rev. 2013;113:2343–2394.
   PubMed Web of Science ®Google Scholar
• Huttenhain R, Soste M, Selevsek N, et al. Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci Transl Med. 2012;4:142ra94.
   PubMed Web of Science ®Google Scholar
• Elschenbroich S, Ignatchenko V, Clarke B, et al. In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry. J Proteome Res. 2011;10:2286–2299.
   PubMed Web of Science ®Google Scholar
• Maurizio E, Wisniewski JR, Ciani Y, et al. Translating proteomic into functional data: an high mobility group A1 (HMGA1) proteomic signature has prognostic value in breast cancer. Mol Cell Proteomics. 2016;15:109–123.
   PubMed Web of Science ®Google Scholar
• Takadate T, Onogawa T, Fukuda T, et al. Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues. Int J Cancer. 2013;132:1368–1382.
   PubMed Web of Science ®Google Scholar
• De Marchi T, Kuhn E, Dekker LJ, et al. Targeted MS assay predicting tamoxifen resistance in estrogen-receptor-positive breast cancer tissues and sera. J Proteome Res. 2016;15:1230–1242.
   PubMed Web of Science ®Google Scholar
• Pavlou MP, Dimitromanolakis A, Martinez-Morillo E, et al. Integrating meta-analysis of microarray data and targeted proteomics for biomarker identification: application in breast cancer. J Proteome Res. 2014;13:2897–2909.
   PubMed Web of Science ®Google Scholar
• Shevchenko A, Jensen ON, Podtelejnikov AV, et al. Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc Natl Acad Sci USA. 1996;93:14440–14445.
   PubMed Web of Science ®Google Scholar
• Jaffe JD, Berg HC, Church GM. Proteogenomic mapping as a complementary method to perform genome annotation. Proteomics. 2004;4:59–77.
   PubMed Web of Science ®Google Scholar
• Castellana N, Bafna V. Proteogenomics to discover the full coding content of genomes: a computational perspective. J Proteomics. 2010;73:2124–2135.
   PubMed Web of Science ®Google Scholar
• Alfaro JA, Sinha A, Kislinger T, et al. Onco-proteogenomics: cancer proteomics joins forces with genomics. Nat Methods. 2014;11:1107–1113.
   PubMed Web of Science ®Google Scholar
• Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–2120.
   PubMed Web of Science ®Google Scholar
• Patel RK, Jain M. NGS QC Toolkit: a toolkit for quality control of next generation sequencing data. PLoS One. 2012;7:e30619
   PubMed Web of Science ®Google Scholar
• Grabherr MG, Haas BJ, Yassour M, et al. Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nat Biotechnol. 2011;29:644–652.
   PubMed Web of Science ®Google Scholar
• Haas BJ, Papanicolaou A, Yassour M, et al. De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis. Nat Protoc. 2013;8:1494–1512.
   PubMed Web of Science ®Google Scholar
• Simpson JT, Wong K, Jackman SD, et al. ABySS: a parallel assembler for short read sequence data. Genome Res. 2009;19:1117–1123.
   PubMed Web of Science ®Google Scholar
• Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–2079.
   PubMed Web of Science ®Google Scholar
• Kim D, Pertea G, Trapnell C, et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:R36.
   PubMed Web of Science ®Google Scholar
• Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21.
   PubMed Web of Science ®Google Scholar
• Li R, Li Y, Kristiansen K, et al. SOAP: short oligonucleotide alignment program. Bioinformatics. 2008;24:713–714.
   PubMed Web of Science ®Google Scholar
• Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357–359.
   PubMed Web of Science ®Google Scholar
• Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26:589–595.
   PubMed Web of Science ®Google Scholar
• Rumble SM, Lacroute P, Dalca AV, et al. SHRiMP: accurate mapping of short color-space reads. PLoS Comput Biol. 2009;5:e1000386.
   PubMed Web of Science ®Google Scholar
• Trapnell C, Williams BA, Pertea G, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28:511–515.
   PubMed Web of Science ®Google Scholar
• Robinson JT, Thorvaldsdottir H, Winckler W, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–26.
   PubMed Web of Science ®Google Scholar
• Fiume M, Williams V, Brook A, et al. Savant: genome browser for high-throughput sequencing data. Bioinformatics. 2010;26:1938–1944.
   PubMed Web of Science ®Google Scholar
• Li H, Ruan J, Durbin R. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 2008;18:1851–1858.
   PubMed Web of Science ®Google Scholar
• McKenna A, Hanna M, Banks E, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–1303.
   PubMed Web of Science ®Google Scholar
• Danecek P, Auton A, Abecasis G, et al. The variant call format and VCFtools. Bioinformatics. 2011;27:2156–2158.
   PubMed Web of Science ®Google Scholar
• Guo Y, Sheng Q, Samuels DC, et al. Comparative study of exome copy number variation estimation tools using array comparative genomic hybridization as control. Biomed Res Int. 2013;2013:915636.
   PubMed Web of Science ®Google Scholar
• Koboldt DC, Zhang Q, Larson DE, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22:568–576.
   PubMed Web of Science ®Google Scholar
• Larson DE, Harris CC, Chen K, et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics. 2012;28:311–317.
   PubMed Web of Science ®Google Scholar
• Roth A, Ding J, Morin R, et al. JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data. Bioinformatics. 2012;28:907–913.
   PubMed Web of Science ®Google Scholar
• Saunders CT, Wong WS, Swamy S, et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics. 2012;28:1811–1817.
   PubMed Web of Science ®Google Scholar
• Cibulskis K, Lawrence MS, Carter SL, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31:213–219.
   PubMed Web of Science ®Google Scholar
• Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;Chapter 7:Unit7.20.
   PubMedGoogle Scholar
• Sim NL, Kumar P, Hu J, et al. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40:W452–W457.
   PubMed Web of Science ®Google Scholar
• Cingolani P, Platts A, Wang le L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6:80–92.
   PubMed Web of Science ®Google Scholar
• Schwarz JM, Cooper DN, Schuelke M, et al. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361–362.
   PubMed Web of Science ®Google Scholar
• Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.
   PubMed Web of Science ®Google Scholar
• Landrum MJ, Lee JM, Riley GR, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980–D985.
   PubMed Web of Science ®Google Scholar
• Landrum MJ, Lee JM, Benson M, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016;44:D862–D868.
   PubMed Web of Science ®Google Scholar
• Seyednasrollah F, Laiho A, Elo LL. Comparison of software packages for detecting differential expression in RNA-seq studies. Brief Bioinform. 2015;16:59–70.
   PubMed Web of Science ®Google Scholar
• Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422:198–207.
   PubMed Web of Science ®Google Scholar
• Patterson SD. Data analysis-the Achilles heel of proteomics. Nat Biotechnol. 2003;21:221–222.
   PubMed Web of Science ®Google Scholar
• Allmer J. Algorithms for the de novo sequencing of peptides from tandem mass spectra. Expert Rev Proteomics. 2011;8:645–657.
   PubMed Web of Science ®Google Scholar
• Ma B. Novor: Real-time peptide de novo sequencing software. J Am Soc Mass Spectrom. 2015;26:1885–1894.
   PubMed Web of Science ®Google Scholar
• Medzihradszky KF, Chalkley RJ. Lessons in de novo peptide sequencing by tandem mass spectrometry. Mass Spectrom Rev. 2015;34:43–63.
   PubMed Web of Science ®Google Scholar
• Eng JK, McCormack AL, Yates JR. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom. 1994;5:976–989.
   PubMed Web of Science ®Google Scholar
• Yates JR III, Eng JK, McCormack AL. Mining genomes: correlating tandem mass spectra of modified and unmodified peptides to sequences in nucleotide databases. Anal Chem. 1995;67:3202–3210.
   PubMed Web of Science ®Google Scholar
• Nesvizhskii AI. Protein identification by tandem mass spectrometry and sequence database searching. Methods Mol Biol. 2007;367:87–119.
   PubMedGoogle Scholar
• Perkins DN, Pappin DJ, Creasy DM, et al. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999;20:3551–3567.
   PubMed Web of Science ®Google Scholar
• Colinge J, Masselot A, Giron M, et al. OLAV: towards high-throughput tandem mass spectrometry data identification. Proteomics. 2003;3:1454–1463.
   PubMed Web of Science ®Google Scholar
• Geer LY, Markey SP, Kowalak JA, et al. Open mass spectrometry search algorithm. J Proteome Res. 2004;3:958–964.
   PubMed Web of Science ®Google Scholar
• Craig R, Beavis RC. TANDEM: matching proteins with tandem mass spectra. Bioinformatics. 2004;20:1466–1467.
   PubMed Web of Science ®Google Scholar
• Tabb DL, Fernando CG, Chambers MC. MyriMatch: highly accurate tandem mass spectral peptide identification by multivariate hypergeometric analysis. J Proteome Res. 2007;6:654–661.
   PubMed Web of Science ®Google Scholar
• Cox J, Neuhauser N, Michalski A, et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res. 2011;10:1794–1805.
   PubMed Web of Science ®Google Scholar
• Wenger CD, Coon JJ. A proteomics search algorithm specifically designed for high-resolution tandem mass spectra. J Proteome Res. 2013;12:1377–1386.
   PubMed Web of Science ®Google Scholar
• Eng JK, Jahan TA, Hoopmann MR. Comet: an open-source MS/MS sequence database search tool. Proteomics. 2013;13:22–24.
   PubMed Web of Science ®Google Scholar
• Kim S, Pevzner PA. MS-GF + makes progress towards a universal database search tool for proteomics. Nat Commun. 2014;5:5277
   PubMed Web of Science ®Google Scholar
• Dorfer V, Pichler P, Stranzl T, et al. MS Amanda, a universal identification algorithm optimized for high accuracy tandem mass spectra. J Proteome Res. 2014;13:3679–3684.
   PubMed Web of Science ®Google Scholar
• Paulo JA. Practical and efficient searching in proteomics: a cross engine comparison. Webmedcentral. 2013;4:pii: WMCPLS0052.
   PubMedGoogle Scholar
• Ma B, Johnson R. De novo sequencing and homology searching. Mol Cell Proteomics. 2012;11:O111.014902.
   PubMed Web of Science ®Google Scholar
• Kim S, Gupta N, Bandeira N, et al. Spectral dictionaries: integrating de novo peptide sequencing with database search of tandem mass spectra. Mol Cell Proteomics. 2009;8:53–69.
   PubMed Web of Science ®Google Scholar
• Chick JM, Kolippakkam D, Nusinow DP, et al. A mass-tolerant database search identifies a large proportion of unassigned spectra in shotgun proteomics as modified peptides. Nat Biotechnol. 2015;33:743–749.
   PubMed Web of Science ®Google Scholar
• Vaudel M, Barsnes H, Raeder H, et al. Using proteomics bioinformatics tools and resources in proteogenomic studies. Adv Exp Med Biol. 2016;926:65–75.
   PubMed Web of Science ®Google Scholar
• Nesvizhskii AI. Proteogenomics: concepts, applications and computational strategies. Nat Methods. 2014;11:1114–1125.
   PubMed Web of Science ®Google Scholar
• Barbieri R, Guryev V, Brandsma CA, et al. Proteogenomics: key driver for clinical discovery and personalized medicine. Adv Exp Med Biol. 2016;926:21–47.
   PubMed Web of Science ®Google Scholar
• Nesvizhskii AI. A survey of computational methods and error rate estimation procedures for peptide and protein identification in shotgun proteomics. J Proteomics. 2010;73:2092–2123.
   PubMed Web of Science ®Google Scholar
• Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods. 2007;4:207–214.
   PubMed Web of Science ®Google Scholar
• Elias JE, Gygi SP. Target-decoy search strategy for mass spectrometry-based proteomics. Methods Mol Biol. 2010;604:55–71.
   PubMedGoogle Scholar
• Karpova MA, Karpov DS, Ivanov MV, et al. Exome-driven characterization of the cancer cell lines at the proteome level: the NCI-60 case study. J Proteome Res. 2014;13:5551–5560.
   PubMed Web of Science ®Google Scholar
• Ning K, Nesvizhskii AI. The utility of mass spectrometry-based proteomic data for validation of novel alternative splice forms reconstructed from RNA-Seq data: a preliminary assessment. BMC Bioinformatics. 2010;11 Suppl 11:S14.
   PubMed Web of Science ®Google Scholar
• Li J, Su Z, Ma ZQ, et al. A bioinformatics workflow for variant peptide detection in shotgun proteomics. Mol Cell Proteomics. 2011;10:M110.006536.
   PubMed Web of Science ®Google Scholar
• Kall L, Canterbury JD, Weston J, et al. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods. 2007;4:923–925.
   PubMed Web of Science ®Google Scholar
• Choi H, Nesvizhskii AI. Semisupervised model-based validation of peptide identifications in mass spectrometry-based proteomics. J Proteome Res. 2008;7:254–265.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang B. customProDB: an R package to generate customized protein databases from RNA-Seq data for proteomics search. Bioinformatics. 2013;29:3235–3237.
   PubMed Web of Science ®Google Scholar
• Risk BA, Spitzer WJ, Giddings MC. Peppy: proteogenomic search software. J Proteome Res. 2013;12:3019–3025.
   PubMed Web of Science ®Google Scholar
• Sheynkman GM, Johnson JE, Jagtap PD, et al. Using Galaxy-P to leverage RNA-Seq for the discovery of novel protein variations. BMC Genomics. 2014;15:703.
   PubMed Web of Science ®Google Scholar
• Wen B, Xu S, Sheynkman GM, et al. sapFinder: an R/Bioconductor package for detection of variant peptides in shotgun proteomics experiments. Bioinformatics. 2014;30:3136–3138.
   PubMed Web of Science ®Google Scholar
• Krasnov GS, Dmitriev AA, Kudryavtseva AV, et al. PPLine: an automated pipeline for SNP, SAP, and splice variant detection in the context of proteogenomics. J Proteome Res. 2015;14:3729–3737.
   PubMed Web of Science ®Google Scholar
• Nagaraj SH, Waddell N, Madugundu AK, et al. PGTools: a software suite for proteogenomics data analysis and visualization. J Proteome Res. 2015;14:2255–2266.
   PubMed Web of Science ®Google Scholar
• Zickmann F, Renard BY. MSProGene: integrative proteogenomics beyond six-frames and single nucleotide polymorphisms. Bioinformatics. 2015;31:i106–i115.
   PubMed Web of Science ®Google Scholar
• Wen B, Xu S, Zhou R, et al. PGA: an R/Bioconductor package for identification of novel peptides using a customized database derived from RNA-Seq. BMC Bioinformatics. 2016;17:244.
   PubMed Web of Science ®Google Scholar
• Askenazi M, Ruggles KV, Fenyo D. PGx: putting peptides to BED. J Proteome Res. 2016;15:795–799.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang X, Cho JH, et al. JUMPg: an integrative proteogenomics pipeline identifying unannotated proteins in human brain and cancer cells. J Proteome Res. 2016;15:2309–2320.
   PubMed Web of Science ®Google Scholar
• Edwards NJ, Oberti M, Thangudu RR, et al. The CPTAC data portal: a resource for cancer proteomics research. J Proteome Res. 2015;14:2707–2713.
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang J, Wang X, et al. Proteogenomic characterization of human colon and rectal cancer. Nature. 2014;513:382–387.
   PubMed Web of Science ®Google Scholar
• Mertins P, Mani DR, Ruggles KV, et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016;534:55–62.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu T, Zhang Z, et al. Integrated proteogenomic characterization of human high-grade serous ovarian cancer. Cell. 2016;166:755–765.
   PubMed Web of Science ®Google Scholar
• Mathivanan S, Ji H, Tauro BJ, et al. Identifying mutated proteins secreted by colon cancer cell lines using mass spectrometry. J Proteomics. 2012;76:141–149.
   PubMed Web of Science ®Google Scholar
• Yang X, Lazar IM. XMAn: a Homo sapiens mutated-peptide database for the MS analysis of cancerous cell states. J Proteome Res. 2014;13:5486–5495.
   PubMed Web of Science ®Google Scholar
• Woo S, Cha SW, Na S, et al. Proteogenomic strategies for identification of aberrant cancer peptides using large-scale next-generation sequencing data. Proteomics. 2014;14:2719–2730.
   PubMed Web of Science ®Google Scholar
• Wang X, Slebos RJ, Wang D, et al. Protein identification using customized protein sequence databases derived from RNA-Seq data. J Proteome Res. 2012;11:1009–1017.
   PubMed Web of Science ®Google Scholar
• Sheynkman GM, Shortreed MR, Frey BL, et al. Large-scale mass spectrometric detection of variant peptides resulting from nonsynonymous nucleotide differences. J Proteome Res. 2014;13:228–240.
   PubMed Web of Science ®Google Scholar
• Ruggles KV, Tang Z, Wang X, et al. An analysis of the sensitivity of proteogenomic mapping of somatic mutations and novel splicing events in cancer. Mol Cell Proteomics. 2016;15:1060–1071.
   PubMed Web of Science ®Google Scholar
• Bassani-Sternberg M, Pletscher-Frankild S, Jensen LJ, et al. Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol Cell Proteomics. 2015;14:658–673.
   PubMed Web of Science ®Google Scholar
• Yadav M, Jhunjhunwala S, Phung QT, et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature. 2014;515:572–576.
   PubMed Web of Science ®Google Scholar
• Woo S, Cha SW, Bonissone S, et al. Advanced proteogenomic analysis reveals multiple peptide mutations and complex immunoglobulin peptides in colon cancer. J Proteome Res. 2015;14:3555–3567.
   PubMed Web of Science ®Google Scholar
• Sun H, Chen C, Lian B, et al. Identification of HPV integration and gene mutation in HeLa cell line by integrated analysis of RNA-Seq and MS/MS data. J Proteome Res. 2015;14:1678–1686.
   PubMed Web of Science ®Google Scholar
• Rivers RC, Kinsinger C, Boja ES, et al. Linking cancer genome to proteome: NCI’s investment into proteogenomics. Proteomics. 2014;14:2633–2636.
   PubMed Web of Science ®Google Scholar
• Lundstrom SL, Zhang B, Rutishauser D, et al. SpotLight Proteomics: uncovering the hidden blood proteome improves diagnostic power of proteomics. Sci Rep. 2017;7:41929.
   PubMed Web of Science ®Google Scholar
• Perez-Riverol Y, Vizcaino JA. Synthetic human proteomes for accelerating protein research. Nat Methods. 2017;14:240–242.
   PubMed Web of Science ®Google Scholar
• Zolg DP, Wilhelm M, Schnatbaum K, et al. Building ProteomeTools based on a complete synthetic human proteome. Nat Methods. 2017;14:259–262.
   PubMed Web of Science ®Google Scholar
• Diamandis EP. Towards identification of true cancer biomarkers. BMC Med. 2014;12:156.
   PubMed Web of Science ®Google Scholar
• Hauschild A, Grob JJ, Demidov LV, et al. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. Lancet. 2012;380:358–365.
   PubMed Web of Science ®Google Scholar
• van der Sligte NE, Kampen KR, de Bont ES. Can kinomics and proteomics bridge the gap between pediatric cancers and newly designed kinase inhibitors? Cell Mol Life Sci. 2015;72:3589–3598.
   PubMed Web of Science ®Google Scholar
• Conlon KP, Basrur V, Rolland D, et al. Fusion peptides from oncogenic chimeric proteins as putative specific biomarkers of cancer. Mol Cell Proteomics. 2013;12:2714–2723.
   PubMed Web of Science ®Google Scholar
• Li C, Takino H, Eimoto T, et al. Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma. Mod Pathol. 2007;20:648–655.
   PubMed Web of Science ®Google Scholar
• Banerji S, Cibulskis K, Rangel-Escareno C, et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature. 2012;486:405–409.
   PubMed Web of Science ®Google Scholar
• Zhang L, Daly RJ. Targeting the human kinome for cancer therapy: current perspectives. Crit Rev Oncog. 2012;17:233–246.
   PubMedGoogle Scholar
• Favicchio R, Thepaut C, Zhang H, et al. Strategies in functional proteomics: unveiling the pathways to precision oncology. Cancer Lett. 2016;382:86–94.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu N, Liu J, et al. FusionCancer: a database of cancer fusion genes derived from RNA-seq data. Diagn Pathol. 2015;10:131.
   PubMed Web of Science ®Google Scholar
• Stransky N, Cerami E, Schalm S, et al. The landscape of kinase fusions in cancer. Nat Commun. 2014;5:4846.
   PubMed Web of Science ®Google Scholar
• Zhao J, Cheng F, Wang Y, et al. Systematic prioritization of druggable mutations in approximately 5000 genomes across 16 cancer types using a structural genomics-based approach. Mol Cell Proteomics. 2016;15:642–656.
   PubMed Web of Science ®Google Scholar
• Kaplun A, Hogan JD, Schacherer F, et al. PGMD: a comprehensive manually curated pharmacogenomic database. Pharmacogenomics J. 2016;16:124–128.
   PubMed Web of Science ®Google Scholar
• Fernandez-Banet J, Esposito A, Coffin S, et al. OASIS: web-based platform for exploring cancer multi-omics data. Nat Methods. 2016;13:9–10.
   PubMed Web of Science ®Google Scholar
• Cheng F, Hong H, Yang S, et al. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era. Brief Bioinform. 2016;18:682–697.
   Web of Science ®Google Scholar
• Robinson DR, Wu YM, Vats P, et al. Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nat Genet. 2013;45:1446–1451.
   PubMed Web of Science ®Google Scholar
• Toy W, Shen Y, Won H, et al. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet. 2013;45:1439–1445.
   PubMed Web of Science ®Google Scholar
• Merenbakh-Lamin K, Ben-Baruch N, Yeheskel A, et al. D538G mutation in estrogen receptor-alpha: a novel mechanism for acquired endocrine resistance in breast cancer. Cancer Res. 2013;73:6856–6864.
   PubMed Web of Science ®Google Scholar
• Nishimura T, Nakamura H. Developments for personalized medicine of lung cancer subtypes: mass spectrometry-based clinical proteogenomic analysis of oncogenic mutations. Adv Exp Med Biol. 2016;926:115–137.
   PubMed Web of Science ®Google Scholar
• Faulkner S, Dun MD, Hondermarck H. Proteogenomics: emergence and promise. Cell Mol Life Sci. 2015;72:953–957.
   PubMed Web of Science ®Google Scholar
• Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012;13:263–269.
   PubMed Web of Science ®Google Scholar
• Polyakova A, Kuznetsova K, Moshkovskii S. Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens. Expert Rev Proteomics. 2015;12:533–541.
   PubMed Web of Science ®Google Scholar
• Gordon SP, Tseng E, Salamov A, et al. Widespread polycistronic transcripts in fungi revealed by single-molecule mRNA sequencing. PLoS One. 2015;10:e0132628.
   PubMed Web of Science ®Google Scholar
• Tilgner H, Grubert F, Sharon D, et al. Defining a personal, allele-specific, and single-molecule long-read transcriptome. Proc Natl Acad Sci USA. 2014;111:9869–9874.
   PubMed Web of Science ®Google Scholar
• Abdel-Ghany SE, Hamilton M, Jacobi JL, et al. A survey of the sorghum transcriptome using single-molecule long reads. Nat Commun. 2016;7:11706.
   PubMed Web of Science ®Google Scholar
• Vollmers C, Penland L, Kanbar JN, et al. Novel exons and splice variants in the human antibody heavy chain identified by single cell and single molecule sequencing. PLoS One. 2015;10:e0117050.
   PubMed Web of Science ®Google Scholar
• Sepiashvili L, Waggott D, Hui A, et al. Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus (HPV)-dependent regulation of the activator protein 1 (AP-1) pathway. Mol Cell Proteomics. 2014;13:3572–3584.
   PubMed Web of Science ®Google Scholar
• Prabakaran S, Hemberg M, Chauhan R, et al. Quantitative profiling of peptides from RNAs classified as noncoding. Nat Commun. 2014;5:5429.
   PubMed Web of Science ®Google Scholar
• Park GW, Hwang H, Kim KH, et al. Integrated proteomic pipeline using multiple search engines for a proteogenomic study with a controlled protein false discovery rate. J Proteome Res. 2016;15:4082–4090.
   PubMed Web of Science ®Google Scholar
• Shanmugam AK, Nesvizhskii AI. Effective leveraging of targeted search spaces for improving peptide identification in tandem mass spectrometry based proteomics. J Proteome Res. 2015;14:5169–5178.
   PubMed Web of Science ®Google Scholar
• Eliuk S, Makarov A. Evolution of Orbitrap mass spectrometry instrumentation. Annu Rev Anal Chem (Palo Alto Calif). 2015;8:61–80.
   PubMed Web of Science ®Google Scholar
• Conrads TP, Petricoin EF III. The Obama Administration’s cancer moonshot: a call for proteomics. Clin Cancer Res. 2016;22:4556–4558.
   PubMed Web of Science ®Google Scholar